Sep 265 minAcesion Pharma Closes Oversubscribed €45M Series B Financing RoundFinancing co-led by new investors Canaan and Alpha Wave, and with participation by the Global BioAccess Fund and existing investor Novo...
May 154 minAcesion Pharma Announces Positive Pre-Clinical Data for AP31969Copenhagen, Denmark – Acesion Pharma (“Acesion” or “the Company”), a biotech company pioneering first-in-class novel therapies for atrial...
Mar 145 minPositive phase 2 data from Atrial Fibrillation clinical trial – primary endpoint metFirst-in-class SK channel inhibition proof of mechanism achieved First new approach to treating Atrial Fibrillation for 20 years...